HIGHLIGHTS
- who: Kensuke Sakuma from the The human iPSC line Ff-I14-s, was kindly provided by the Center for iPS Cell Research and Application (CiRA) at the Kyoto UniversityThe Ff-I14s, line was established as an HLA homozygous iPSC line in a previous study [19]. The use of the iPSC line was approved by the Ethical Review Committee of the Shonan Health Innovation Park (Fujisawa, Kanagawa, Japan) and Kyoto University (#CiRA18-27). Cells were cultured and maintained on dishes coated by iMatrix, (Nippi, Tokyo, Japan) in StemFit AK N (Ajinomoto, Tokyo, Japan) at , u00b0C in a humidified . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.